RETINOID X receptor (RXR) plays a central role in the regulation a of
many intracellular receptor signalling pathways(1) and can mediate lig
and-dependent transcription, acting as a homodimer or as a heterodimer
(1-6). Here we identify an antagonist towards RXR homodimers which als
o functions as an agonist when RXR is paired as a heterodimer to speci
fic partners, including peroxisome proliferator-activated receptor and
retinoic acid receptor. This dimer-selective ligand confers different
ial interactions on the transcription machinery: the antagonist promot
es association with TAF110) (TATA-binding protein (TBP)-associated fac
tor 110) and the co-repressor SMRT(7), but not with TBP, and these pro
perties are distinct from pure RXR agonists. This unique class of RXR
ligands will provide a means to control distinct target genes at the l
evel of transcription and allow the development of retinoids with a ne
w pharmacological action.